CA3290557A1 - Uricase variants and methods of use thereof - Google Patents

Uricase variants and methods of use thereof

Info

Publication number
CA3290557A1
CA3290557A1 CA3290557A CA3290557A CA3290557A1 CA 3290557 A1 CA3290557 A1 CA 3290557A1 CA 3290557 A CA3290557 A CA 3290557A CA 3290557 A CA3290557 A CA 3290557A CA 3290557 A1 CA3290557 A1 CA 3290557A1
Authority
CA
Canada
Prior art keywords
methods
uricase variants
uricase
variants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3290557A
Other languages
French (fr)
Inventor
Chris BAILEY-KELLOGG
Karl Griswold
Patrick WIENCEK
Claire GODBERSEN-PALMER
Hongki SONG
Matthew Miller
Adam Plaunt
Nicholas Rosenthal
Sasha ROSE
Original Assignee
Insmed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Insmed Inc filed Critical Insmed Inc
Publication of CA3290557A1 publication Critical patent/CA3290557A1/en
Pending legal-status Critical Current

Links

CA3290557A 2023-05-05 2024-05-03 Uricase variants and methods of use thereof Pending CA3290557A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63/500,541 2023-05-05

Publications (1)

Publication Number Publication Date
CA3290557A1 true CA3290557A1 (en) 2024-11-14

Family

ID=

Similar Documents

Publication Publication Date Title
IL315305A (en) Improved igg-degrading enzymes and methods of use thereof
CA3262145A1 (en) Aza-quinazoline compounds and methods of use
CA3265648A1 (en) Novel recombinases and methods of use
CA3263259A1 (en) Mussel-inspired tissue adhesives and methods of use thereof
CA3255793A1 (en) Angiotensinogen-modulating compositions and methods of use thereof
CA3290557A1 (en) Uricase variants and methods of use thereof
CA3276166A1 (en) Uricase conjugates and methods of use thereof
HK40121183A (en) Improved igg-degrading enzymes and methods of use thereof
CA3278511A1 (en) Solid forms and methods of use
CA3276109A1 (en) Formulations and methods of use
HK40118445A (en) Cas12a endonuclease variants and methods of use
HK40124187A (en) Pyrimidopyrimidone compounds and methods of use thereof
HK40120643A (en) Aza-quinazoline compounds and methods of use
HK40120392A (en) Compounds and methods of use
CA3248829A1 (en) Anti-b7-h3 compounds and methods of use
CA3243625A1 (en) Nanomaterial and methods of use thereof
CA3296259A1 (en) Hydrogel formulations and methods of use thereof
HK40113415A (en) Jak2 inhibitors and methods of use thereof
CA3288470A1 (en) Mrgprx2 inhibitors and methods of use thereof
AU2021903580A0 (en) Rna ligase enzymes and methods of preparation and use thereof
AU2024367226A1 (en) Rotating t-clip and methods of use
AU2020901533A0 (en) Formulations and methods of use
CA3295113A1 (en) Cd74 car-t therapy and methods of use thereof
CA3270038A1 (en) Improved horse jump and methods of use
CA3289796A1 (en) Molecules and methods of use thereof